Open official notice

柳韓堂/GCOOP JAPAN "Processed food containing oat dietary fiber: General Balance Dekashin" - Stop using

Official notice

6 Feb 2025

Last checked

27 Oct 2026

RecallScope risk estimate:HighCAA Japan

An official CAA Japan notice concerns 柳韓堂/GCOOP JAPAN "Processed food containing oat dietary fiber: General Balance Dekashin" - Stop using. The possibility of harm to health from consuming this product cannot be ruled out (it was found to contain Angelica gigas root). 【Discovery of a product containing a pharmaceutical ingredient】 The Tokyo Metropolitan Government investigated after receiving information that symptoms including elevated liver function test values had occurred following consumption of the product sold in Tokyo, although a causal relationship had not been established. The investigation found that the product contained the pharmaceutical ingredient Angelica gigas root. So-called health foods containing pharmaceutical ingredients are regarded as pharmaceuticals. Selling, supplying or otherwise distributing such products manufactured and marketed without approval from the Minister of Health, Labour and Welfare is prohibited under the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices (hereinafter, the Pharmaceuticals and Medical Devices Act). To date, no reports of harm to health caused by this product have been received apart from the information that prompted this investigation. 【Violation】 Article 55, paragraph 2 of the Pharmaceuticals and Medical Devices Act (prohibition on selling, supplying or otherwise distributing unapproved pharmaceuticals). 【Reference】 Angelica gigas Nakai is a perennial plant in the Apiaceae family. Its root is listed among ingredients (raw materials) used exclusively as pharmaceuticals. Its leaves are listed among ingredients (raw materials) that are not considered pharmaceuticals unless pharmaceutical efficacy or effects are claimed. Angelica gigas root is also included in the Korean Pharmacopoeia, which lists decursin, decursinol angelate and nodakenin as analytical marker compounds. Published 2025-02-06.

What to do now

Because the possibility of harm to health from consuming this product cannot be ruled out, anyone who has this product should stop using it immediately. If you suspect harm to your health, promptly seek medical attention. 【Tokyo Metropolitan Government response】 1. The product's importer and distributor were instructed to stop sales and conduct a voluntary recall. 2. The product name and other information will be published on the official Tokyo Metropolitan Government website to inform residents about the risks of consumption. 3. Information was provided to relevant organizations to raise awareness.

Official notice

2025-02-06

The hazard

The possibility of harm to health from consuming this product cannot be ruled out (it was found to contain Angelica gigas root). 【Discovery of a product containing a pharmaceutical ingredient】 The Tokyo Metropolitan Government investigated after receiving information that symptoms including elevated liver function test values had occurred following consumption of the product sold in Tokyo, although a causal relationship had not been established. The investigation found that the product contained the pharmaceutical ingredient Angelica gigas root. So-called health foods containing pharmaceutical ingredients are regarded as pharmaceuticals. Selling, supplying or otherwise distributing such products manufactured and marketed without approval from the Minister of Health, Labour and Welfare is prohibited under the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices (hereinafter, the Pharmaceuticals and Medical Devices Act). To date, no reports of harm to health caused by this product have been received apart from the information that prompted this investigation. 【Violation】 Article 55, paragraph 2 of the Pharmaceuticals and Medical Devices Act (prohibition on selling, supplying or otherwise distributing unapproved pharmaceuticals). 【Reference】 Angelica gigas Nakai is a perennial plant in the Apiaceae family. Its root is listed among ingredients (raw materials) used exclusively as pharmaceuticals. Its leaves are listed among ingredients (raw materials) that are not considered pharmaceuticals unless pharmaceutical efficacy or effects are claimed. Angelica gigas root is also included in the Korean Pharmacopoeia, which lists decursin, decursinol angelate and nodakenin as analytical marker compounds.

How to check if you're affected

Product identifiers are not currently available in RecallScope. Check the official notice before deciding whether your item is affected.

Checked manually this time?

Follow brands and keywords in the app to receive alerts for matching official notices.

Turn on recall alerts

Affected products

Product 1

オート麦食物繊維含有加工食品 ゼネラルバランス デカシン

Hazard

The possibility of harm to health from consuming this product cannot be ruled out (it was found to contain Angelica gigas root). 【Discovery of a product containing a pharmaceutical ingredient】 The Tokyo Metropolitan Government investigated after receiving information that symptoms including elevated liver function test values had occurred following consumption of the product sold in Tokyo, although a causal relationship had not been established. The investigation found that the product contained the pharmaceutical ingredient Angelica gigas root. So-called health foods containing pharmaceutical ingredients are regarded as pharmaceuticals. Selling, supplying or otherwise distributing such products manufactured and marketed without approval from the Minister of Health, Labour and Welfare is prohibited under the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices (hereinafter, the Pharmaceuticals and Medical Devices Act). To date, no reports of harm to health caused by this product have been received apart from the information that prompted this investigation. 【Violation】 Article 55, paragraph 2 of the Pharmaceuticals and Medical Devices Act (prohibition on selling, supplying or otherwise distributing unapproved pharmaceuticals). 【Reference】 Angelica gigas Nakai is a perennial plant in the Apiaceae family. Its root is listed among ingredients (raw materials) used exclusively as pharmaceuticals. Its leaves are listed among ingredients (raw materials) that are not considered pharmaceuticals unless pharmaceutical efficacy or effects are claimed. Angelica gigas root is also included in the Korean Pharmacopoeia, which lists decursin, decursinol angelate and nodakenin as analytical marker compounds.

Where it was sold

Retailer information is not currently available in RecallScope. Check the official notice for distribution details.

Location 1

JP · Japan

Affected area 1

JP · Japan

Company & contacts

Manufacturer

保健医療局健康安全部薬務課

Phone

03-5320-4512

Brand: 柳韓堂 Gcoop Japan. Contact: 保健医療局健康安全部薬務課. Phone 03-5320-4512.

Source & status

Source

Tier

official

Category

FOOD

Official classification

消費者庁 — 使用中止

Recall details

Event id

CAA-00000033435

Source tier

official

Documents, notices & source

See the official notice and source documents for full details.

View full official notice
Something wrong on this page?

Weekly recall digest

Get next week's recalls before you need them.

One email every Monday — official-source recalls for your country, and nothing else. Unsubscribe from any email.

The digest arrives once a week. For matching recall alerts after notices are processed, get the app.

This recall was published 6 Feb 2025. The next one won't wait for you to search.

RecallScope checks listed publishers for the brands and VINs you follow, and can alert you when a matching notice is processed.

apple-buttongoogle-button